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ABSTRACT 
 
Introduction. Pterygium has been a problematic disease throughout human history, owing its 
major tendency to recur after surgical removal. The factors causing primary pterygium and also 
those causing recurrence have been greatly investigated over the centuries. Many theories have 
been proposed along with countless surgical procedures aimed at preventing recurrence. 
Material and Methods. In the 1990s simple excision and use of Mitomycin C (MMC) or free 
sutured conjunctival autografts were advocated as the best approach to managing pterygia. We 
compared these two methods in a randomized fashion at the St. Eriks Eye Hospital (Paper 1). All 
patients were operated on by a single surgeon (GK) and followed up in a regular, standardized 
manner. We followed our patients for four years in order to determine the method of choice for 
the future. Autografting turned out to be the best method and was chosen for use during the 
following years. 
To shorten the surgery time, Tisseel Duo Quick, a fibrin-based tissue adhesive was tried instead 
of sutures to secure the autograft. We discovered that apart from the time for the procedure, 
postoperative patient discomfort had also been diminished. Therefore, a randomized controlled 
study was designed to compare suturing to gluing the conjunctival transplant (Paper 2). During 
the following years, the number and severity of recurrences also seemed to decrease. A 
retrospective study with long-term follow up was designed and performed, and we were able to 
confirm our discovery (Paper 3). 
The Cut and Paste method has gained popularity in Sweden and elsewhere, and several 
ophthalmologists were guided by the inventor (GK). At the St. Eriks Eye Hospital two other 
ophthalmologists were also trained in the technique. In order to evaluate the learning curve, the 
rates of recurrence and complications when other ophthalmologists use the Cut and Paste method, 
the first 120 cases operated on by these surgeons were studied and compared with the results of 
GK (Paper 4). 
Results. Autografting turned out to have the lowest recurrence rate and fewest complications. It 
was therefore chosen as the preferred procedure (Paper 1). We demonstrated that gluing the 
transplant was fast, safe and caused significantly less postoperative pain than sutures (Paper 2). In 
a long-term comparative study, we showed that recurrence rate and complications were lower 
when the autograft was glued rather than sutured (Paper 3). After other ophthalmologists were 
trained, there were only slight differences in recurrence rates and complications, and no 
significant learning curve was seen (Paper 4). 
Conclusions. This thesis investigates the development and other aspects of the Cut and Paste 
method for surgery of primary pterygium. Conjunctival autografting was first shown to be 
superior to the technique of bare sclera with peroperative use of MMC. Then, the Cut and Paste 
method was shown to be even better, with less patient discomfort, shorter surgery time, and lower 
recurrence rate. Furthermore, we found it easy to teach and learn. This approach has also gained 
popularity and appreciation in Sweden and all over the world. 
Hence, we propose Cut and Paste as the method of choice when operating on primary pterygium. 
 
Key words: Pterygium, primary, fibrin glue, tissue adhesive, conjunctival autograft, Mitomycin 
C, learning curve. 
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AIMS OF THE THESIS 
 
The purpose of this thesis was to present a new surgical technique for managing primary 
pterygium. Our aim was to find a more effective method than the one previously in use. 
We wanted to demonstrate and prove that we found such a technique, the Cut and Paste method, 
and that it has low recurrence rates, minimal postoperative pain and requires short surgery time. 
In addition, it is a procedure which is easy to learn and teach. 
Finally, we wanted to show how much it has become appreciated and used all over the world.  
 
  
INTRODUCTION 
 
Definition and description of pterygium 
The term pterygium comes from the ancient Greek πτερυξ (pteryx) = wing and πτερυγιον 
(pterygion) = fin. Pterygium is characterized by a triangular portion of the bulbar conjunctiva 
encroaching onto the cornea1, usually within the intrapalpebral fissure and most often from the 
nasal side. 
Pterygium is most common in the so-called “pterygium area”, which is defined by a geographical 
latitude of 40° north and south of the equator1. In this area, prevalence of up to 22% has been 
reported2,3. In countries outside of this area reported prevalence rates usually do not exceed 2% of 
the general population, and the lesion affects mostly patients with an extensive exposure to 
sunlight4,5. 
 
  Source: the World Wide Web 
 
Pterygium seldom presents before 12 years of age. It evolves slowly over the years, growing from 
the limbus towards the center of the cornea. Sometimes, in about 1-2% it appears on both the 
nasal and the temporal sides. Classifications have been created based on size, rate of growth, 
fleshiness and visual impairment6. Typically, both eyes are affected, often with the lesion in the 
dominant eye preceding that in the other. 
Anatomically, pterygia can be subdivided into the head and the body aspects. 
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Histopathologically, elastotic degeneration of the conjunctival stroma is considered to be 
pathognomonic7, although, excessive fibroproliferative reaction in the stroma has long been 
recognized8. Epithelial changes such as hyperkeratosis, parakerathosis and akanthosis have also 
been described9. 
Body 
Head 
  
Symptoms associated with pterygium development include chronic ocular surface inflammation 
and tearing, eventually astigmatism and blurred vision attributable to optical axis involvement1. 
The natural history of the condition is variable, prolonged static periods do exist. However, 
progressive growth characterizes the majority of cases of pterygia, especially those affecting 
younger individuals, often necessitating surgical removal. 
This acquired condition occurs around the world. Its cause and proper treatment have long been 
uncertain10 and still surprisingly little is known about this common disorder. 
  
PATHOGENESIS OF PTERYGIUM 
 
There are several theories on the etiology of pterygium. Both internal and external factors have 
been suggested. 
Pterygium has long been believed to be an environmental disease. There is regional variation of 
pterygium distribution in the world, with higher occurrence closer to the Equator1 suggesting the 
impact of UV light. The effects of UV-A and UV-B (280-400 nm) are considered particularly 
detrimental11. Prevalence differences may also be explained by differences in lifestyle12. People 
working and living outdoors have shown be more affected. Multivariate logistic analysis in an 
Australian population has identified risk factors including hazel-green eye color, red hair, skin 
burns, time spent outdoors and use of sunglasses13. 
Periorbital architecture, including the presence of eyebrows and nasal prominence imply that the 
eyes are well protected from direct light exposure from above. On the other hand, the eyes are 
relatively unprotected from light scattered laterally and from below (the albedoeffect of the snow, 
water and sand). The possible impact of this scattered UV light, which could cause death of the 
corneal epithelial stem cells on the nasal limbus, has been shown by Coroneo et al14,15.  
 
 
Courtesy of Prof. Minas Coroneo, Chairman of the Department of Ophthalmology, University of NSW, Australia. 
The temporally incident light is focused at the nasal limbus where pterygia usually are formed. 
 
It was suggested that the scattered light might follow a transcameral optical pathway, hitting and 
altering the nasally positioned limbal epithelial stem cells. 
Genetically defective or injured limbal stem cells with altered matrix metalloproteinases have 
shown to play an important role in the etiology of pterygium16,17.  
Focal limbal failure is a key feature. Conjunctivalisation of the cornea occurs, with tissue 
characterized by extensive chronic-inflammation, cellular proliferation, connective tissue 
remodeling, and angiogenesis. This theory has gained popularity in recent years. 
Viral etiology from HSV and HPV has been suggested by some authors18. Other studies have 
found abnormal p53 tumour suppressor gene expression in pterygium, suggesting a possible 
relation19 owing to oxidative stress. Hereditary factors have also been considered2,20 and shown21. 
However, it was not possible to verify whether the pterygium itself is inherited as an independent 
trait or if the affected individuals shared increased susceptibility to the oculodermal effects of 
sunlight. To date, no specific genetic locus has been associated with pterygium development. 
  
SURGICAL INTERVENTION 
 
Pterygium surgery may lead to further clinical manifestations, including conjunctival scars 
affecting ocular motility, corneal clouding, delayed epithelial healing. Postoperative recurrence 
rates could have been up to 50% of the cases. The basic goals of good pterygium surgery are to 
cleanly remove pterygium tissue from the ocular surface and to prevent recurrence. Today, 
satisfactory cosmetic results are also a concern22. 
Pterygium and its treatment have been described since ancient India by Susruta in approximately 
1000 BC: “… the pterygium is loosened … with the patient looking laterally. A sharp hook is 
used to secure the growth … the pterygium is gotten rid of by scratching it with a sharp, round 
topped instrument …“. “The condition disturbs both the patient, because of its appearance, and 
the surgeon because of the tendency to recur in a matter of weeks or months”. In order to avoid 
recurrence, pterygia have been “incised, removed, split, transplanted, excised, cauterized, grafted, 
inverted, galvanized, heated, dissected, rotated, coagulated, repositioned and irradiated”23. 
Pterygium was also mentioned by Hippocrates around 400 B.C.24  He treated it with eye drops 
made of lead, zinc, copper, iron, bile juices, urine and maternal milk. Celsus (25 BC) and Galenus 
(129 AD) also advocated complex topical solutions. Avicenna (1000 AD) proposed cutting the 
pterygium with scissors23. 
Historically, there has been a common understanding that surgery is the only way to cure the 
disease. Medical treatments, chemical cauterization and laser therapies have all been used and 
abandoned. However, recently anti-VEGF therapy25 has been tried with some success. Many 
different methods of pterygium surgery have been advocated and used, some with unpredictable 
and poor results, due to the propensity to recur23. 
Proper reconstructive surgery began in the nineteenth century with Scarpa, Arlt (use of 
conjunctival graft), Desmarres and Knapp. Elschnig (1926) performed advanced conjunctival 
plastic surgery. β-irradiation26 began to be used in the 1950s and the use of MMC as adjunct 
therapy27 began in Japan in the 1960s. Amniotic membrane to substitute the conjunctiva28 was 
used as early as in 1946 but the idea was developed and popularized by Tseng29 in the 1990s. 
Pterygium surgery today still varies from the simplest procedure of bare sclera excision to 
complex surgery such as sclerokeratoplasty30 and amniotic membrane transplantation with or 
without tissue adhesive31. 
Simple excision and suturing of the conjunctiva to the sclera (bare sclera technique) gives a high 
percentage of recurrences32,33. The rationale for the bare sclera technique was that the area left 
uncovered would be epithelialized by epithelial cells from the anchored conjunctival rim, which 
could then act as a barrier against pterygium regrowth. However, up to 50% recurrence rates have 
been reported32 with this technique. Therefore, adjunct therapies such as beta-irradiation34 and 
chemotherapeutics such as MMC35 have been tried. Unfortunately, there were not only low 
recurrence rates but also reports of serious side effects36,37. These adjunctive medical therapies are 
still in use: β-irradiation38 with Strontium 90, topical Thiotepa39 and topical MMC40 in spite of the 
documented risk of adverse effects such as delayed healing, keratitis, scleral and corneal melting, 
and endophthalmitis41. 
Understanding the important role of normal conjunctiva in blocking recurrence was the basis for 
surgical modifications of the initial technique. These include different conjunctival flaps attached 
to the pterygium bed42.  
Kenyon et al. published the use of a free conjunctival autograft in 198543. This was shown to 
result in great improvements44. The method was first discouraged for use in primary pterygia 
because it was time consuming and difficult to master, but it has slowly emerged to be the golden 
standard thanks to the good results and the fear of the serious complications with the other 
procedures. 
  
In cases with large conjunctival defects created following pterygium excision, preserved human 
amniotic membrane can be used, as was first suggested by Tseng and coworkers29.  
The first known Swedish paper on pterygium surgery was written by Prof. J G Pipping in 1799, 
where two patients and bare sclera surgery were described45. Since then, the surgery technique in 
Sweden seems to have followed the practice elsewhere in the world. At the St. Eriks Eye Hospital 
in the early 1990s suturing of sliding conjunctival flaps was the common procedure for primary 
pterygium46, with moderately high recurrence rates, in line with other reports in the literature47. 
Conjunctival autografts were used mainly for recurrent pterygia as recommended by Kenyon et 
al48. After having tried the bare sclera with intraoperative MMC and sutured autoconjunctival 
transplants, the Cut and Paste technique was introduced in 1999 (Paper 2).  
 
 
 
  
MATERIALS AND METHODS 
 
Patients 
During the study period almost all pterygium patients in Stockholm were operated on at the St. 
Eriks Eye Hospital; thus a cross-section of the entire population living there. Since the area has 
many immigrants, only about 50% of our patients were from Northern Europe. 18% were from 
the Middle East 18% Northern Africa of Latin origin and the rest from the Far East. The gender 
distribution was even. The mean age was 48.5 years (range 18-97). Dropouts were less than 10%, 
and follow up times were between 6 months and 4 years. 
 
Mitomycin C 
The mitomycins are a family of natural products isolated from Streptomyces species. One of 
these, mitomycin C, from streptomyces caesiptosus is an antibiotic, capable of alkylating the 
DNA double helix and blocking both transcription and translation49. Thus, MMC is also a potent 
inhibitor of cancer cells. MMC has been given intravenously as well as topically. Given 
systemically it causes bone marrow damage, lung fibrosis and renal damage. Topical use for 
mucosal cancer as bladder instillation has been widespread. Its use and side effects in eye surgery, 
particularly pterygium surgery were described50 as early as in the 1960s and many times since. 
Both trabeculectomy and pterygium surgery gained great benefits from its use, however delayed 
epithelialisation, corneal and scleral melting, fungal keratitis and even endophthalmitis have also 
been reported51,52. In pterygium surgery, MMC is often used intraoperatively in concentrations of 
0.2-0.4 mg/ml episclerally or subconjunctivally for 2-3 minutes. Therapy as postoperative eye 
drops has also been tried35. 
In our study (Paper 1) we used 0.4mg/ml MMC preoperatively for 3 minutes on the scleral bed. 
 
Sutures 
In our studies 7/0 Vicryl Rapide sutures were used to secure the free conjunctival graft in order to 
achieve quick resolution of the suture. The suture characteristics provided rapid strength loss and 
softening/dissolving of the suture material. Thus, there was no need for suture removal. All this 
meant less discomfort for the patient. 
 
Tisseel Duo Quick 
Since ancient times, people have dreamt of gluing together parts of the body. There are tales from 
the classical Greeks about using resin to improve wound healing. In 1905, Morawitz showed that 
calcium ions transformed pro-thrombin to thrombin in the blood, which turned fibrinogen to 
fibrin53. 
 
Prothrombin Thrombin
Fibrinogen Fibrin (monomer)
Ca++
Ca++
Fibrin clot
insoluble
Tissue factor
Fibrin (polymer)
soluble
Factor XIII
Factor XIIIa
Ca++
 
 
During the 1940s, blood plasma was used in animal studies to glue peripheral nerve fibers, and 
human skin transplantation was also tried. The strength of the glue was unsatisfactory until the 
1970s, when Matras published the results of his studies with different fibrin preparations54 which 
led to registration of Tisseel, a fibrin adhesive. 
  
Tisseel consists of 2 components:  
a) mixture of fibrinogen, fibronectin, factor XIII, plasminogen and aprotinin  
b) thrombin with calcium chloride solution.  
Mixing a) and b) initiates a coagulation cascade and a relatively strong tissue adhesive is formed. 
The reaction time can be controlled by varying the concentration of the thrombin (4 IU/ml or 500 
IU/ml). The strength of the fibrin sealant reaches 70% at 3-5 minutes and 100% in 2 hours. 
Degradation takes about two weeks according to the manufacturer, but in our clinical 
ophthalmologic practice we have seen it disappear within a few days. Tisseel is mainly 
manufactured from human plasma checked for various antigens such as HIV, Hepatitis A, B and 
C. Aprotinin, however, is of bovine origin and could cause allergic/anaphylactic reactions when 
used repeatedly in heart surgery, mastectomy and nasal mucosa haemostasis55,56,57,58 which has 
been a concern, although this adverse reaction has never been observed or described in eye 
surgery.
  
THE CUT AND PASTE TECHNIQUE 
 
The use of fibrin sealant in eye surgery was first described in 1978 for corneal surgery59 and for 
conjunctiva in 1984 by Buschman et al60. By 1999, about 50 more papers regarding fibrin glue 
had been published, but only one on pterygium surgery61. 
In 2000 we presented our first Cut and Paste study62 and since then more than 100 manuscripts 
containing use of fibrin sealant in the human eye have been published, mostly on conjunctival and 
pterygium surgery. 
The surgery is mainly done under local anesthesia. In the beginning, subconjunctival or 
subtenonal injections were used. This evolved to only topical oxybuprocain 0.4% (Chauvin 
Pharmaceuticals Ltd. London, UK) and tetracain 1% (Chauvin Pharmaceuticals Ltd. London, 
UK) eye drops. Today, we use lidocain 2% gel (Xylocain, Astra Zeneca AB, Södertälje, Sweden). 
A tunnel is created between the sclera and the pterygium neck at the limbus, using scissors. Blunt 
avulsion of the pterygium head follows. This can be done for example with an iris spatula.  The 
exposed cornea is scraped clean with a crescent formed knife to achieve a smooth and even 
surface. Gentle diathermy of the bleeding vessels follows. Then the free limbal conjunctival graft 
is prepared as free from Tenon’s tissue as possible. Subconjunctival injection of saline can be 
helpful. The size of the graft should be somewhat larger than the uncovered sclera. Before cutting 
off the limbus, the conjunctival flap lies with its epithelial side on the cornea. It is then separated 
from the limbus and is slid nasally to a position opposing the scleral site. One drop of each of the 
two components of the fibrin glue is placed onto the sclera and onto the graft respectively. The 
graft is then flipped over, smoothed out and pressed onto the scleral bed for 20-30 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 2 components of the 
fibrin glue are placed onto 
the backside of the free flap 
and the bare sclera
The free graft is flipped 
over and glued onto the 
sclera 
The head of the pterygium 
is separated from the cornea 
by blunt dissection 
The body of the pterygium 
is excised. A conjunctival 
flap is created superiorly  
  
Postoperatively rimexolone eye drops (Vexol, Alcon Laboratories, Hempstead, UK) 6 times daily 
and fucidic acid ointment (Fucithalmic, Leo Pharma, Malmö, Sweden) 2 times daily are given for 
the first week, thereafter the fucidic acid is discontinued and the rimexolone tapered weekly for 5 
additional weeks.
  
GUIDANCE 
 
During the years a large number of ophthalmologists have been trained in this method in Sweden 
(at 13 eye clinics) and abroad (Bergen, Norway; Budapest, Hungary; Mumbai, India) according to 
the following program: 
5-6 patients with nasal primary pterygium were gathered. The first patient of the day was operated 
on by GK assisted by the trainee instead of a scrub nurse. The next patient was operated on by the 
trainee with assistance of GK. Then we discussed the difficulties and GK did the next surgery, 
again showing the details of the technique. The remaining patients were operated on by the 
trainee. Surgeons at the St. Erik’s Eye Hospital could, if necessary, ask for assistance during the 
following days but others were left to develop their surgery on their own. One example of the 
result of this teaching is a paper published 2007 in Hungary63, where the recurrence rate was 
5.9%, another is the paper of Ayala from Örebro in 200864 with a recurrence rate of 4.5%. 
 
 
 
 
 
 
  
RESULTS 
 
The recurrence rates with bare sclera excision and MMC was 38% compared to 15% that with 
conjunctival autografting with sutures (p<0.05). The reoperation rates were 53% and 29% 
respectively. Average surgery time was 13 minutes and 28 minutes. There were no significant 
changes in visual acuity or in astigmatism. The results showed that apart from the time of the 
procedure, conjunctival autografting was superior to surgery with bare sclera and intraoperative 
use of MMC. 
Operating with fibrin glue instead of sutures lowered the average pain measured with VAS 
significantly (p<0.05). That was true both for the initial pain on the operating day and every day 
during the first postoperative week. 
 
 
 
Postoperative pain measured twice daily by VAS, adjusted to preoperative pain threshold. 
 
Average time for the surgery was significantly shorter, 9.7 minutes and 18.5 minutes respectively 
(p<0.001). 
Recurrence rates were 5.3% and 13.5% (p<0.01) and reoperation rates were 1.2% and 3.3% 
(p<0.05) respectively in the long-term study. Complications occurred equally in both groups. 
When training other ophthalmologists (A and B) at St. Eriks Eye Hospital mean surgery time was 
17 minutes and 13 minutes respectively compared to 13 minutes for GK. There was a slight 
learning curve slope for surgeon A but not for surgeon B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Temporal distribution of operation times for surgeon A, B and GK (C beginner, D experienced). 
 
Recurrence rates were 8.9% and 6.8% respectively, not significantly different from that of GK 
(5%). The temporal distribution of recurrences did not show any learning curve.
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THE CUT AND PASTE METHOD IN SWEDEN AND 
INTERNATIONALLY 
 
A questionnaire was sent to all 42 ophthalmology clinics in Sweden. 
The questions were: 
1. Which method do you use when performing primary pterygium surgery? 
2. What is your recurrence rate? 
3. Are you satisfied with your results? 
4. If applicable, when did you start using the “Cut and Paste” technique and how did you learn it? 
5. If applicable, how did the change of method alter the indications for surgery? 
  
The Medline database was also searched for pterygium surgery using autologous conjunctival 
transplantation with fibrin adhesive. 
 
Results 
34 (81%) answers to the questionnaire were obtained. Of these 34 Swedish ophthalmology 
clinics, 7 did not performed pterygium surgery at all. Twenty-two (81%) of the remaining 27 used 
the Cut and Paste method and all of them were satisfied with the results. Thirteen of these 27 had 
been trained personally by GK. Some started using the technique in 2001, some as late as in 2010. 
Ten of the 22 (45%) using the Cut and Paste method answered that the change of method had 
resulted in wider indications and earlier surgery. 
Five (19%) clinics applied different techniques: bare sclera, MacReynolds, bare sclera with MMC 
and suturing of the conjunctiva and two used only suturing. 4 of these clinics were satisfied with 
their results. 
None of the clinics had reliable statistics of the recurrence rates, 16 did not know at all, 7 reported 
<1% assumed recurrence rate and the rest approximately 5%. 
 
Medline search with the words “pterygium, conjunctival, fibrin” resulted in 35 hits. Our papers 
were referenced in 17 of these articles. After excluding the review articles and our papers 14 
relevant original articles were found. All reported less postoperative discomfort and fewer 
complications with fibrin glue than with sutures. The average number of patients was 34 (total 
474, range 9-92) and the average recurrence rate was 3.1% (range 0%-9%).  The authors were 
working in different countries including India, Singapore, New Zeeland, Australia, Brazil, UK, 
USA, Canada, Korea, China and others, which indicates widespread use of the method.  
  
DISCUSSION 
 
We found that pterygium excision with sutured conjunctival autograft results in a statistically 
significant lower recurrence rate than the bare sclera method combined with intraoperatively 
0.04% MMC. There is a considerable variation of the recurrence rates in the literature65. We think 
that relatively small sample sizes are an important factor causing differences in the reports. Our 
results are in line with other reports on this method66,65. Kenyon emphasized the method of using 
free autologous conjunctival grafts in pterygium surgery early48. This technique is considered 
safe, but surgically more demanding and time-consuming. In our study the average surgery time 
in this group was 26 min, twice as long as the average surgery time in the MMC group. The 
greatest advantage of our first study is its long follow-up period of 4 years. All recurrences after 
pterygium surgery appeared within a year which is consistent with earlier findings: Hirst and co-
workers showed that there is a 50% chance for a recurrence after pterygium surgery to occur 
within 4 months and a 97% chance within 1 year67. In another article on recurrence time68 it is 
shown that 1-year follow-up is optimal, which also coincides with our results.  
The cut and paste method was the first surgical method developed to address patient discomfort, 
especially postoperative pain and surgical time. In addition, postoperative patching, healing time 
and restrictions in normal life after surgery were of concern. Evaluating pain is not easy because 
patients report different sensitivity for the same stimulus. In addition, they have different capacity 
to withstand the pain. Furthermore, they have different ability to report their experience. 
Prospective series in the literature report recurrence rates of 2–39% after pterygium surgery using 
sutured conjunctival autografts69,32 . Wide excision of the nasal Tenon’s tissue, better quality of 
the graft or different suture techniques might possibly explain the low numbers of recurrences in 
some other studies. The recurrence rates in our hands when using sutures (13.8%) is in 
accordance with these results. We expected the long-term recurrence rate for glued grafts to be 
similar to that of sutured grafts, but it turned out to be only 5.4%. 
There is always some reparative inflammation following surgery. Since the glue components 
form pure human fibrin,  it does not give rise to additional inflammation. In contrast to glue, the 
presence of sutures causes significantly more postoperative pain70. This may be caused by an up-
regulated inflammatory process around the sutures during degradation71. Both silk and nylon 
sutures placed in the conjunctiva can cause inflammation, and migration of Langerhans’ cells to 
the cornea72. More severe inflammation may cause higher recurrence rates73. 
Conjunctival autografting has been considered to be difficult and time consuming and was first 
advocated only for recurrent pterygia48,74,75. Despite of this, pterygium surgery is often seen as a 
trivial procedure and delegated to less experienced surgeons32,47,73,76.  
The authors propose a learning curve effect, change of surgery technique, better education and 
supervising. We could not find any reference on learning curve analysis in pterygium surgery, 
thus, our paper could be the first attempt. We do not see pterygium surgery as a trivial procedure 
and residents do not perform this surgery. Instead, ophthalmologists are educated in this task. We 
think that the differences in average operation time rather mirror the personal character of a 
surgeon than the difficulty of the surgical method. 
Our impression has been that performing more pterygium procedures the same day promoted the 
skills and confidence of both surgeons and nurses and shortened the surgery time. 
Adequate follow up, small number of drop out cases and the fact that all surgeries were done in a 
similar fashion are strength of our study. We have also analysed a large number of pterygium 
surgeries for each surgeon, more than in earlier studies on learning effects in eye surgery42,73,76. 
  
CONCLUSIONS 
 
Pterygium surgery with sutured free autologous conjunctival grafting was associated with fewer 
recurrences, fewer reoperations and fewer complications than the bare sclera technique together 
with a single intraoperative dose of MMC. 
The Cut and Paste technique in pterygium surgery resulted in significantly less postoperative pain 
and shorter surgery times than using sutures. Furthermore, this surgery resulted in a significantly 
lower recurrence rate and fewer complications. 
Our study also indicates that the Cut and Paste technique is easy to learn and master.  
We suggest that Cut and Paste surgery should be considered as the first method of choice for 
primary pterygia. The surgery should be performed by “large volume surgeons” and concentrated 
to sessions of 5-10 procedures. 
  
SHORT PRESENTATION OF THE ORIGINAL PAPERS 
 
Paper 1. 
At St. Eriks Eye Hospital it was decided in 1993 that all pterygia should be operated on by a 
single surgeon (GK). In order to improve the recurrence rates, literature research was done. This 
revealed that bare sclera surgery with postoperative MMC eye drops had low recurrence rates, but 
owing to the fear of the side effects also intraoperative use of MMC was taken into consideration. 
Transplantation of conjunctival autograft was considered the best methods in the literature but 
difficult surgery and prolonged surgery time were concerns. 
Therefore, a study was planned to compare the results of intraoperative MMC with the results of 
the conjunctival autograft technique in a prospective, randomized trial with very long-term follow 
up. Conjunctival autotransplantation appeared to be significantly more effective in terms of 
recurrence rates than bare sclera with a single intraoperative dose of MMC. With the modified 
technique developed by Shaw, the surgery times of autografting was only about 25 minutes. The 
recurrences after MMC were more aggressive and demanded additional surgery at higher rates. 
Complications also appeared to be more frequent in the latter group.  
Therefore, we decided to use the conjunctival autograft when operating all cases of pterygia as the 
preferred technique. In addition, since not any late onset recurrences appeared, we suggested that 
12 months of follow up would be satisfactory for future studies of pterygium surgery. 
During the following years, almost all cases of pterygia in Stockholm were directed to our 
hospital owing to our good postoperative results. A vast amount of experience in this type of 
surgery was thus developed. 
 
Paper 2. 
In 1999 our researchers were searching for modulators when performing phototherapeutic 
keratectomy in order to correct irregular corneas. One of the investigated substances was a fibrin 
adhesive, Tisseel Duo Quick. Since the author of the present thesis (GK) was involved, the 
thought of attaching the conjunctival autograft in pterygium surgery with this glue instead of 
sutures arose. The goal was to shorten the surgery time. 
The idea was tried out and we discovered that along with the shorter and easier operation, patient 
discomfort and postoperative complaints also diminished. A study was designed to compare 
surgery time and postoperative pain when securing the autograft with glue vis-à-vis sutures. The 
postoperative pain was measured on the standardized Visual Analogue Scale. The surgery time 
was measured in minutes from the subconjunctival anesthesia until the draping was removed. 
The results confirmed the initial impression and the study was first presented at AAO 2000 in 
Dallas, Texas. According to these results, the surgery indications were changed to involve 
subjective symptoms together with pterygium size and visual impairment. This resulted in a larger 
number of operations and a great deal of experience being gained. The method was spread, taught 
in different courses and on site in certain hospitals in Sweden and abroad (Bergen, Norway 2001) 
as well as in live surgery at ophthalmologic meetings (Bombay, India 2004, Budapest, Hungary 
2007). 
 
Paper 3. 
We were very pleased with our results and also noted that the recurrences were fewer and smaller. 
This led to the next project, a comparison of recurrence rates. 
All pterygium surgery were still performed by the same surgeon (GK) and was followed up like 
the previous sutured transplants. This produced a database that could be compared with that from 
the earlier method. We confirmed our impression, which we presented at ARVO 2001. The 
retrospective comparative study with a large number of patients and a long follow up time 
revealed that the recurrence rate of the sutured transplants was 3 times higher than that of the 
  
glued ones. The recurrences of the pterygia operated on with fibrin adhesive were also smaller, 
less troublesome and required reoperation less frequently. 
Other authors began to publish their results with the same technique, confirming our results. 
 
Paper 4. 
To diminish the workload on the single surgeon and to increase the availability of the surgery, 
other surgeons were also involved; Wijk T 2002 and Artzén D 2003. They were taught to perform 
the surgery in the same manner and used the same postoperative regimen and follow up. 
When analysing their outcome, we did not find a significant learning curve regarding surgery 
time, recurrences or complications. We think that reported success rates may depend on patient 
factors, surgeon factors and lesion characteristics. We also believe that general surgeon qualities 
and devotion, more than the learning curve for the method affects surgery time, complications and 
recurrence rates. It is important that trainees get adequate instructions and support from qualified 
consultants. In this context we were interested in whether the Cut and Paste method was easy to 
learn and what happened in terms of complications and recurrences. Others have reported that 
inexperienced surgeons had worse results than senior ophthalmologists when learning to suture 
conjunctival autografts. It turned out that at our hospital this did not apply, the two surgeons had 
almost the same results and almost no learning curve with the Cut and Paste technique. 
  
SAMMANFATTNING PÅ SVENSKA 
 
Pterygium är en triangulär bindhinneduplikatur som växer över hornhinnan. Genom tusentals år i 
mänsklighetens historia har det varit en besvärlig sjukdom, som ofta orsakat lidande och t.o.m. 
blindhet. Det kunde inte botas med mediciner och nästan alltid recidiverade efter kirurgiska 
ingrepp. Man har länge sökt dess orsak och varför det återkommer efter dess avlägsnande. Många 
teorier har föreslagits och ännu fler kirurgiska metoder har testats med mer eller mindre bra 
resultat. Gemensamt för dessa var att pterygiumhuvudet och en del av bindehinnan över 
senhinnan skulle avlägsnas. 
På 1990-talet ansågs enkel excision av pterygiet med tillägg av Mitomycin C vara en bra 
operationsmetod. Svårare fall eller recidiv opererades med suturering av fri bindhinnelambå över 
den blottade senhinnan. På S:t Eriks Ögonsjukhus i Stockholm jämförde vi dessa tekniker på 
slumpmässigt utvalda patienter (Paper 1). Alla opererades och följdes upp av samma kirurg (GK). 
Vi kontrollerade patienterna i 4 år. Operation med bindhinnelambå visade sig vara överlägsen, 
recidivfrekvensen var 15% mot 38% i MMC-gruppen och den valdes som vår standardmetod. Vi 
kunde också visa att recidiv uppträder under det första postoperativa året, alltså 1 års uppföljning i 
framtida studier kommer att räcka vid beräkning av recidivfrekvensen.  
1999 testade vi att ersätta suturerna med ett välkänt fibrinlim, Tisseel Duo Quick, för att kunna 
förkorta operationstiden. Våra förväntningar infriades och vi upptäckte dessutom att patienterna 
upplevde klart mindre obehag postoperativt. Vi utformade och genomförde då den första 
jämförande studien (Paper 2) som övertygande bevisade våra intryck. Smärtupplevelsen enligt 
VAS-skalan var signifikant lägre (p<0.05) och operationstiden blev också signifikant kortare 9.7 
mot 19.5 minuter (p<0.01). Vi kallade den nya operationsmetoden för Cut and Paste (klippa och 
klistra). 
Under följande år användes endast denna teknik och med tiden såg vi att antalet recidiv var färre 
än förväntat. Vi utförde då en retrospektiv jämförande studie av dessa två metoder (Paper 3). 
Utfallet blev 5.3% resp. 13.5% (p<0.01). Reoperationsfrekvensen var också lägre, 1.2% resp. 
3.3% (p<0.05). 
Metoden började få gott rykte och ögonläkare vid andra svenska och utländska kliniker ville 
också lära sig den. Vid St. Eriks Ögonsjukhus fanns det behov av fler operatörer och två 
ögonläkare (A och B) utan tidigare erfarenhet av pterygiumkirurgi blev introducerade. Vi passade 
på att undersöka hur svårt det var att lära sig och bemästra denna operationsteknik. Vi opererade 
flera fall av primära pterygier under samma dag så att GK och eleven opererade varannan patient. 
Vi utvärderade sedan resultaten efter de första 120 operationerna av vardera kirurg och jämförde 
det med GK-s resultat (Paper 4). Medelvärdet för operationstiden var 17 resp 13 minuter för A 
och B, och 13 minuter för GK. Recidivfrekvensen var 8.9% resp 6.8% som inte skiljde sig 
signifikant från GK-s (5%). Varken operationstiderna eller recidivfrekvensen visade någon 
signifikant ökning under studieperioden. 
Med en enkätundersökning bland svenska ögonkliniker och genom litteratursökning har vi sett att 
Cut and Paste metoden har blivit populär både i Sverige och i stora delar av världen samt att våra 
resultat har upprepats och bekräftats av andra. 
Vi föreslår den som första val vid operation av primära pterygier. 
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